Literature DB >> 12466234

Functional characterization of tachykinin NK1 receptors in the mouse uterus.

Eva Patak1, Jocelyn N Pennefather, Anna Fleming, Margot E Story.   

Abstract

1. Contractility studies were undertaken to determine the nature of the receptors mediating responses to tachykinins in uteri of oestrogen-treated mice. 2. In the presence of thiorphan (3 microM), captopril (10 microM), and bestatin (10 microM), substance P (SP), neurokinin A (NKA) and neurokinin B (NKB) produced concentration-related contractions of uterine preparations. The order of potency was SP > or =NKA>NKB. 3. Neither atropine (0.1 microM) nor l-NOLA (100 microM), nor indomethacin (10 microM) alone or in combination with either ranitidine (10 microM) or mepyramine (10 microM), affected responses to SP. These findings indicate that SP actions are not mediated or modulated through the release of acetylcholine, nitric oxide, prostanoids or histamine. 4. In the presence of peptidase inhibitors, the tachykinin NK(1) receptor-selective agonist [Sar(9)Met(O(2))(11)]SP, produced a concentration-dependent contractile effect. The tachykinin NK(2) and NK(3) receptor-selective agonists [Lys(5)MeLeu(9)Nle(10)]NKA(4-10) and [MePhe(7)]NKB were relatively inactive. The potencies of SP analogues in which Glu replaced Gln(5) and/or Gln(6) were similar to that of SP. 5. The tachykinin NK(1) receptor-selective antagonist, SR140333 (10 nM), alone or combined with the tachykinin NK(2) receptor-selective antagonist, SR48968 (10 nM), shifted log concentration curves to SP, NKA and NKB to the right. SR140333 (10 nM) reduced the effect of [Sar(9)Met(O(2))(11)]SP. SR48968 did not affect responses to SP or [Sar(9)Met(O(2))(11)]SP, but reduced the effect of higher concentrations of NKA and shifted the log concentration-response curve to NKB to the right. The tachykinin NK(3) receptor-selective antagonist, SR 142801 (0.3 microM), had little effect on responses to SP and NKB. 6. We conclude that the tachykinin NK(1) receptor mediates contractile effects of SP, NKA and NKB and [Sar(9)Met(O(2))(11)]SP in myometrium from the oestrogen-primed mouse. The tachykinin NK(2) receptor may also participate in the responses to NKA and NKB.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12466234      PMCID: PMC1573619          DOI: 10.1038/sj.bjp.0704996

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

1.  Murine stress-triggered abortion is mediated by increase of CD8+ TNF-alpha+ decidual cells via substance P.

Authors:  R A Joachim; M Hildebrandt; J Oder; B F Klapp; P C Arck
Journal:  Am J Reprod Immunol       Date:  2001-05       Impact factor: 3.886

2.  Activation of neurokinin NK(2) receptors by tachykinin peptides causes contraction of uterus in pregnant women near term.

Authors:  E N Patak; S Ziccone; M E Story; A J Fleming; A Lilley; J N Pennefather
Journal:  Mol Hum Reprod       Date:  2000-06       Impact factor: 4.025

3.  Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation.

Authors:  F Lembeck; P Holzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

4.  Peptide-immunoreactive nerves in the mammalian female genital tract.

Authors:  W M Huang; J Gu; M A Blank; J M Allen; S R Bloom; J M Polak
Journal:  Histochem J       Date:  1984-12

5.  Changes in the expression of tachykinin receptors in the rat uterus during the course of pregnancy.

Authors:  M L Candenas; J Magraner; C P Armesto; E Anselmi; P M Nieto; J D Martín; C Advenier; F M Pinto
Journal:  Biol Reprod       Date:  2001-08       Impact factor: 4.285

6.  Expression of preprotachykinin-B, the gene that encodes neurokinin B, in the rat uterus.

Authors:  F M Pinto; C G Cintado; P Devillier; M L Candenas
Journal:  Eur J Pharmacol       Date:  2001-08-10       Impact factor: 4.432

7.  Mechanisms underlying the neurokinin A-induced contraction of the pregnant rat myometrium.

Authors:  Y Shintani; J Nishimura; N Niiro; K Hirano; H Nakano; H Kanaide
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

Review 8.  Effects of tachykinins on uterine smooth muscle.

Authors:  E N Patak; J N Pennefather; M E Story
Journal:  Clin Exp Pharmacol Physiol       Date:  2000-11       Impact factor: 2.557

9.  Involvement of tachykinin receptors in oedema formation and plasma extravasation induced by substance P, neurokinin A, and neurokinin B in mouse ear.

Authors:  H Inoue; N Nagata; Y Koshihara
Journal:  Inflamm Res       Date:  1996-07       Impact factor: 4.575

10.  The potential of the immunogold-silver staining method for paraffin sections.

Authors:  D R Springall; G W Hacker; L Grimelius; J M Polak
Journal:  Histochemistry       Date:  1984
View more
  1 in total

1.  Tachykinins and tachykinin receptors in human uterus.

Authors:  Eva Patak; M Luz Candenas; Jocelyn N Pennefather; Sebastian Ziccone; Alison Lilley; Julio D Martín; Carlos Flores; Antonio G Mantecón; Margot E Story; Francisco M Pinto
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.